Edition:
India

Wockhardt Ltd (WCKH.NS)

WCKH.NS on National Stock Exchange of India

290.50INR
3:58pm IST
Change (% chg)

Rs9.70 (+3.45%)
Prev Close
Rs280.80
Open
Rs281.90
Day's High
Rs292.90
Day's Low
Rs276.30
Volume
475,486
Avg. Vol
887,300
52-wk High
Rs411.65
52-wk Low
Rs146.70

Latest Key Developments (Source: Significant Developments)

Wockhardt Intends To Supply 30 Mln Fill-&-Finish COVID-19 Vaccine Doses To AstraZeneca
Monday, 3 Aug 2020 

Aug 3 (Reuters) - Wockhardt Chairman Habil Khorakiwala::SAYS CO HAS COMBINED FILL FINISH COVID-19 VACCINE DOSE MANUFACTURING CAPACITY, INCLUDING INDIA & UK, OF 1 BILLION DOSES.SAYS HAVE BEEN IN TOUCH WITH SCIENTIFIC ADVISER TO INDIA PM'S OFFICE, HAVE OFFERED CO'S VACCINE MANUFACTURING CAPACITY.SAYS ASTRAZENECA INDICATED THEY WOULD NEED 30 MILLION FILL FINISH COVID-19 VACCINE DOSES, CO INTENDS TO SUPPLY IT IN NEXT FEW MONTHS.SAYS CO HAS FILL FINISH COVID-19 VACCINE DOSE MANUFACTURING CAPACITY OF 400 MILLION DOSES IN UK, 600 MILLION DOSES IN INDIA.SAYS INDIAN GOVERNMENT. HAS NOT COME BACK TO CO YET WITH REGARDS TO FILL & FINISH COVID-19 VACCINE DOSE MANUFACTURING IN INDIA.  Full Article

Wockhardt Gets US FDA Qualified Infectious Disease Product Designation For WCK 6777
Monday, 20 Apr 2020 

April 20 (Reuters) - Wockhardt Ltd ::RECEIVES US FDA QUALIFIED INFECTIOUS DISEASE PRODUCT DESIGNATION FOR WCK 6777.  Full Article

India's Wockhardt Posts Dec-Quarter Consol Net Profit Vs Loss Year Ago
Monday, 27 Jan 2020 

Jan 27 (Reuters) - Wockhardt Ltd ::DEC-QUARTER CONSOL NET PROFIT 96.3 MILLION RUPEES VERSUS LOSS OF 711.1 MILLION RUPEES YEAR AGO.DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 8.69 BILLION RUPEES VERSUS 10.46 BILLION RUPEES YEAR AGO.  Full Article

Wockhardt Says Class Action Was Initiated Against Pharmaceutical Companies Including Co
Tuesday, 14 May 2019 

May 14 (Reuters) - Wockhardt Ltd ::SAYS A CLASS ACTION WAS INITIATED AGAINST VARIOUS PHARMACEUTICAL COMPANIES INCLUDING WOCKHARDT LIMITED.SAYS DOES NOT ANTICIPATE THAT CLASS ACTION WILL HAVE A MATERIAL IMPACT ON THE BUSINESS OR OPERATIONS OF THE COMPANY.AS REGARDS CO'S EXPOSURE TO RISK AND POTENTIAL LIABILITIES, SEE MINIMAL EXPOSURE.  Full Article

India's Wockhardt Ltd Gets UK Regulator Nod for Daman Plant
Monday, 13 May 2019 

May 13 (Reuters) - Wockhardt Ltd ::EUDRAGMDP DATABASE REFLECTS CERTIFICATES BY UK MHRA STATING UNITS DAMAN COMPLIES WITH GOOD MANUFACTURING PRACTICES OF MHRA.  Full Article

Wockhardt Says No Observations Made After USFDA Inspection Of Bioequivalence Centre, Aurangabad
Monday, 15 Apr 2019 

April 15 (Reuters) - Wockhardt Ltd ::USFDA CARRIED OUT INSPECTION OF BIOEQUIVALENCE CENTRE LOCATED AT RESEARCH AND DEVELOPMENT CENTRE, AURANGABAD.BIOEQUIVALENCE STUDIES OF TAMSULOSIN 0.4MG CAPSULES AND METOPROLOL TARTRATE 200MG ER TABLETS WERE AUDITED.AT END OF INSPECTION, THERE WAS NIL OBSERVATION.  Full Article

Wockhardt Gets U.S. FDA Approval For Prostate Cancer Drug
Friday, 1 Mar 2019 

March 1 (Reuters) - Wockhardt Ltd ::RECEIVES US FDA APPROVAL FOR PROSTATE CANCER DRUG.GETS U.S. FDA APPROVAL FOR AN ANDA FOR 250MG TABLET OF ABIRATERONE ACETATE.  Full Article

India's Wockhardt Dec-Quarter Consol Net Loss Widens
Monday, 28 Jan 2019 

Jan 28 (Reuters) - Wockhardt Ltd ::DEC QUARTER CONSOL NET LOSS 711.1 MILLION RUPEES VERSUS LOSS OF 407.6 MILLION RUPEES LAST YEAR.DEC QUARTER CONSOL REVENUE FROM OPERATIONS 10.46 BILLION RUPEES VERSUS 10.05 BILLION RUPEES LAST YEAR.  Full Article

Wockhardt Gets U.S. FDA Approval For Leukemia Drug
Monday, 21 Jan 2019 

Jan 21 (Reuters) - Wockhardt Ltd ::WOCKHARDT RECEIVES US FDA APPROVAL FOR LEUKEMIA DRUG.CO WILL BE LAUNCHING PRODUCT IN THE UNITED STATES, IN A SHORT PERIOD OF TIME.PRODUCT IS BEING MANUFACTURED AT A CONTRACT MANUFACTURING FACILITY, BASED NEAR HYDERABAD, INDIA.  Full Article

FACTBOX-EU tries to catch-up after U.S., UK spend billions to secure coronavirus vaccines

(Adds ReiThera; updates Sanofi, AstraZeneca, Novavax, Johnson & Johnson) Sept 21 The United States and United Kingdom are leading a rush to strike deals with drugmakers to reserve supplies of experimental coronavirus vaccines. The European Union also signed its first supply deal with AstraZeneca last month, and is in talks with several other companies. The following is a list of supply deals that give some countries a guarantee of a limited number of doses: COUNTRY/RE